Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report

There’s no deal to report, but sources are telling the business news service that uniQure has brought in advisers to see what might be done — including a sale — with the pharma giants now prowling the clinical players for partners and acquisitions.